EUVIMEDEUVIMED entdecken
EditorialKommentar

The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease)

Colin M Dayan iD

The Journal of Clinical Endocrinology & Metabolism · 16.09.2024 · 109 (10) · e1938-e1939

DOI: 10.1210/clinem/dgad693 ↗

Kurz gefasst

Editorial in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 07.03.2024. Verfasst von Colin M Dayan. Beteiligte Einrichtung: Thyroid Research Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK. Hauptthemen laut MEDLINE: Graves Ophthalmopathy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves OphthalmopathyHumans

Stichwörter der Autor:innen

FcRnGraves diseaseGraves orbitopathyclinical trialthyroid eye diseasethyroid stimulating immunoglobulins

Autor:innen und Institutionen

  • Thyroid Research Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

ORCID-Profile: Colin M Dayan

Zitieren

APA

Dayan, C. M. (2024). The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease). The Journal of Clinical Endocrinology & Metabolism, 109(10), e1938-e1939. https://doi.org/10.1210/clinem/dgad693

Vancouver

Dayan CM. The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease). The Journal of Clinical Endocrinology & Metabolism. 2024;109(10):e1938-e1939. doi:10.1210/clinem/dgad693

BibTeX
@article{Dayan2024,
  author = {Dayan, Colin M},
  title = {The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease)},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  volume = {109},
  number = {10},
  pages = {e1938--e1939},
  doi = {10.1210/clinem/dgad693}
}
Kostenlos starten →